Study of an investigational drug in healthy volunteers
This is a first-in-human study to test an investigational drug called PSTB100 in healthy adults. The purpose is to see how the body handles the drug and to check for any side effects. Participation may help with future treatment development.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old (or 18-45 for a special group).
- You must have a body mass index (BMI) between 18 and 32.
- You must be in good general health, confirmed by medical checks.
- You must agree to use contraception if you or your partner can have children.
- You must not have taken any medications or supplements recently.
- You must avoid certain foods and activities before the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called PSTC100 in healthy adults to see if it is safe and how the body handles it. It is a Phase 1 trial, which means the medicine is still early in testing, and your participation could help find out if it might help people with certain conditions later.
This study tests a new investigational drug called ID110521156 in healthy adults. The goal is to see if the drug is safe and how the body processes it. It may be for people who are overweight or obese.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This trial tests different doses of a new study drug in healthy people to see how safe it is and how the body handles it. Participation involves taking the drug and having regular check-ups.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This study tests a new medicine called TESP-0401 in healthy people to see if it is safe and how the body handles it. It is an early-stage trial, and you will stay at a clinic for part of the study.
Hear when a new Healthy Adult Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.